Jan 31, Toronto, Ont. - Theralase Technologies Inc. is pleased to announce that it has been granted notified body approval to place the CE mark on its TLC-1000 series of products, clearing the way for sale of its laser products throughout all 30 member states of the European Union (EU).
CE approval is a mandatory approval stage in the sale of products to European Union (EU) countries. It serves as a declaration that the product meets EU consumer safety, health and environmental requirements.
“Achieving CE approval allows Theralase another opportunity to expand the sale of our medical lasers internationally", stated Roger Dumoulin-White, President and CEO of Theralase Technologies Inc. "By possessing CE approval, in addition to our Health Canada, FDA and certain Latin American and Asian approvals, we are now able to sell our medical lasers to over 63 per cent of the worldmarket (as measured by GDP). This presents a great opportunity for Theralase to expand our revenue generation capability beyond our present markets."
For more information visit the corporate or regulatorywebsite at
www.theralase.com or www.sedar.com
Theralase approved for Europe
Insurers question value of massage therapy – a signal of changes to come?How many of your patients pay using their employee health…
Osteopathy 101 for massage therapistsHave you ever wondered what Osteopathy is all about?
Exercise: psych patients’ new primary prescriptionWhen it comes to inpatient treatment of a range of…
Sleep problems in teenagers reversed in just one week by limiting screen useSleep in teenagers can be improved by just one week…
Remedial Massage Therapists Association AGM and Conference
September 13, 2019
Massage Therapist Association of Alberta AGM
October 7, 2019